First Turn Management, LLC

First Turn Management, LLC reported 38 holdings worth US$753M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

First Turn Management, LLC reported 38 holdings worth US$753M as of Sep 30, 2026. Largest: Enliven Therapeutics, Inc., Guardant Health, Inc. and Abivax SA. Filed Nov 16, 2026 (Form 13F).

Holdings
38
Value as reported
US$753M

The filing in full

CompanySharesValue as reported% of portfolio
Enliven Therapeutics, Inc.959KUS$43.9M5.8%
Guardant Health, Inc.219KUS$39.1M5.2%
Abivax SA385KUS$38.1M5.1%
Roivant Sciences Ltd.986KUS$36M4.8%
United Therapeutics Corporation60,064US$32.5M4.3%
Viridian Therapeutics, Inc.1.53MUS$31.4M4.2%
Axsome Therapeutics, Inc.162KUS$29.9M4.0%
Insmed Incorporated246KUS$28M3.7%
Celcuity Inc.329KUS$26.2M3.5%
Charles River Laboratories International, Inc.86,801US$25.6M3.4%
Cytokinetics, Incorporated358KUS$23.6M3.1%
BridgeBio Pharma, Inc.354KUS$23.3M3.1%
Praxis Precision Medicines, Inc.78,806US$23M3.0%
ORIC Pharmaceuticals, Inc.1.57MUS$21.2M2.8%
Repligen Corporation108KUS$20.8M2.8%
Tango Therapeutics, Inc.767KUS$19.1M2.5%
Revolution Medicines, Inc.92,316US$18.9M2.5%
Inhibrx Biosciences, Inc.172KUS$17.2M2.3%
Veradermics, Incorporated137KUS$16.6M2.2%
Cogent Biosciences, Inc.515KUS$16.5M2.2%
Dianthus Therapeutics, Inc.179KUS$15.7M2.1%
Palvella Therapeutics, Inc.110KUS$15.2M2.0%
Rhythm Pharmaceuticals, Inc.158KUS$15M2.0%
Arcus Biosciences, Inc.578KUS$14.9M2.0%
Arrowhead Pharmaceuticals, Inc.223KUS$14.6M1.9%
Disc Medicine, Inc.221KUS$14.4M1.9%
Erasca, Inc.913KUS$13.4M1.8%
GRAIL, Inc.93,727US$13.1M1.7%
Kymera Therapeutics, Inc.113KUS$12.7M1.7%
Xenon Pharmaceuticals Inc.297KUS$11M1.5%
Spyre Therapeutics, Inc.103KUS$9.13M1.2%
Summit Therapeutics Inc.502KUS$8.48M1.1%
Definium Therapeutics, Inc.217KUS$8.24M1.1%
Vaxcyte, Inc.138KUS$7.83M1.0%
Hinge Health, Inc.75,448US$7.34M0.97%
Oruka Therapeutics, Inc.0US$00.00%
Scholar Rock Holding Corporation0US$00.00%
Sionna Therapeutics, Inc.0US$00.00%
Apogee Therapeutics, Inc.0US$00.00%
Mirum Pharmaceuticals, Inc.0US$00.00%
Nuvalent, Inc.0US$00.00%

Source

Download original · View original at SEC

Related